The fight against cancer receives a boost with a groundbreaking AI-powered cancer detection tool. This innovative test utilizes a single drop of blood to potentially identify three prevalent cancer types within minutes.
Early trials showcased the tool’s ability to differentiate between individuals with pancreatic, gastric, or colorectal cancers and healthy subjects – all in a remarkably short timeframe. The test analyzes specific blood chemicals, achieving an impressive success rate of 82% to 100% in pinpointing the presence of cancer.
This AI-powered cancer detection method leverages machine learning, a form of artificial intelligence. The technology scrutinizes blood metabolites, byproducts generated by the body during food breakdown. These metabolites, residing within the blood serum (liquid component), function as biomarkers, potentially revealing the presence or absence of cancer.
This cancer diagnosing test also clarifies the purpose of metabolites and emphasizes the early detection potential.
